» Available Technologies

The following technologies are available for licensing. Please do not hesitate to contact Lawrence Lau, Director of Industry Alliances & Commercialization at lalau@chapman.edu for more information. 

Case Number

Invention Title

17-03

Rapid Selective Detection of Bacteria

18-01

"Novel neuronal nitric oxide synthase (nNOS) inhibitors for the immunotherapy of human melanoma patients", joint invention with Northwestern University

19-01

"Particles for Targeted Delivery and Uses in Managing Bleeding or Blood Clotting", joint invention with Emory University

2020-001

Targeting Primary Cilia with Nanoparticles

2020-005

Targeted Peptide-Drug Conjugates to Overcome Multi-Drug Resistance in Cancer

2020-008 Variable Light Diffuser for Plant Leaf Gas Exchange Measurements
2020-009 Targeting Polycystic Kidney Disease with Nanomedicines
2022-002 Bis-Cinnamamide Derivatives as Novel APE/Ref-1 Inhibitors for the Treatment of Human Melanoma

2021-003

SK Channel Positive Allosteric Modulators

2022-003 A Small Peptide Increases Drug Delivery in Human Melanoma Cells
2022-004 Enzymatic Break Down of Chlorogenic Acid in Sunflower Meal and Butter for Baking
2023-005

Super Interferometric Range Resolution

2023-006

Passive Single-Photon Detector

2024-002

Biochemical Biomarkers for Kidney Diseases

2024-001-003

Low Power Latches for Different Precision Needs

2024-004

De Novo Drug Design Using Transformer-Based Machine Translation and Reinforcement Learning of an Adaptive Monte Carlo Tree Search